CIRIN finishes financial year 2007-08 with 45% growth over last year in sales revenue. This growth rate is up from 23% registered in 2006-07 and 13% in 2005-06.
IMS places CIRIN in third group (based on turnover) of top tier (based on sustained growth rate) pharmaceutical firms operating in Pakistan. Management is hopeful of shifting to second group in top tier by the end of 2009 (i.e. amongst companies with turnover between Rs. 500Million - Rs. 1Biliion).
No comments:
Post a Comment